These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 32314041)

  • 21. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
    Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
    Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis.
    Carpenter DH; El-Mofty SK; Lewis JS
    Mod Pathol; 2011 Oct; 24(10):1306-12. PubMed ID: 21572403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.
    Clark J; Jeffery CC; Zhang H; Cooper T; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):37. PubMed ID: 26374294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
    BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
    Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.
    Drop B; Strycharz-Dudziak M; Kliszczewska E; Polz-Dacewicz M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma.
    von Buchwald C; Jakobsen KK; Carlander AF; Tous S; Grønhøj C; Rasmussen JH; Brooks J; Taberna M; Mena M; Morey F; Bruni L; Batis N; Brakenhoff RH; René Leemans C; Jong RJB; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Anderson LA; Craig SG; Alemany L; Mehanna H;
    Eur J Cancer; 2024 Nov; 211():114329. PubMed ID: 39293346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.
    Isaac A; Kostiuk M; Zhang H; Lindsay C; Makki F; O'Connell DA; Harris JR; Cote DW; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):5. PubMed ID: 28088212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
    Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
    Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil.
    Afonso LA; Moyses N; Alves G; Ornellas AA; Passos MR; Oliveira Ldo H; Cavalcanti SM
    Mem Inst Oswaldo Cruz; 2012 Feb; 107(1):18-23. PubMed ID: 22310531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
    Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
    J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
    Wang Z; Xia RH; Ye DX; Li J
    PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer.
    Wong M; Pagano JS; Schiller JT; Tevethia SS; Raab-Traub N; Gruber J
    J Natl Cancer Inst; 2002 Dec; 94(24):1832-6. PubMed ID: 12488476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.